The founder and CEO of the Invitro medical group, Alexander Ostrovsky, is leaving the company, and Roman Mironchik becomes its new shareholder. A. Ostrovsky announced this on July 20 in a letter to Invitro employees, the Kommersant newspaper writes.
As A. Ostrovsky noted in the letter, with a new shareholder, the company should continue its development and reach a new level.
"The change of the shareholder will not affect the current activities of the company, the operational management of which continues to be carried out by Yulia Polikhova," says a representative of Invitro, referred to by Kommersant.
Invitro has been in existence since 1995, specializing in laboratory diagnostics and the provision of medical services. It unites more than 1.9 thousand medical offices in Russia, Belarus, Kazakhstan, Armenia and Kyrgyzstan. The head structure of Invitro is the Cyprus Invitro Holding ltd., whose co-owners were Alexander Ostrovsky, Valentin Doronichev and Vladimir Kulikovsky. Russia Partners funds had another 30%.
